A new collaboration between academic and industry researchers could help to improve clinical decision making for cancer patients – including by potentially guiding the use of immunotherapy to breast ...
Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This ...
Radiotherapy can be used alongside hormone treatment, delaying the need for chemotherapy and therefore significantly protecting their quality of life for some patients with advanced prostate cancer, ...
Pancreatic cancer is notorious for being highly aggressive and difficult to treat. Survival rates for this disease have barely improved at all in the last four decades, with only five per cent of ...
From mapping the paths of cancer evolution, to the design and discovery of novel drugs - we are leading in innovative cancer informatics. Cancer is a complex, ever-changing set of diseases, and new ...
Employees from land developer Socius have donned their running shoes to raise money for The Institute of Cancer Research – as members of our 2024 London Marathon team. Socius’ Head of Engagement Liam ...
Lucy works in the quality assurance team in the Governance Office at Mount Vernon Hospital and was diagnosed with breast cancer in 2019. Lucy ran the London Marathon this year in just over four and a ...
It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to ...
As a fit and healthy former firefighter, Harry Hall didn’t think there was anything to worry about when he developed a lump in his neck. But after his wife persuaded him to go to the doctors, tests ...
It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to ...
It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to ...
It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback